/Investor DB

Hummingbird Ventures — 2019 Investments

3 investments dated 2019 · listed companies and verified rows first · show all

BillionToOnebilliontoone.comin𝕏NASDAQ: BLLNSeries A · Mar 2019 · $15M

BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Oguzhan Atay(Founder)inDavid Tsao(CTO)inSukrit Silas(Founder)inBrett Huff(Director of Engineering)Mihir Sewak(Software Engineering Manager)Jen Katzburg(Principal Recruiter)

Co-investors500 Emerging Europe500 GlobalAsymmetry VenturesCivilization Ventures Management, Llce2vcFifty Years+23 more

Khatabookkhatabook.comin𝕏Series A · Oct 2019 · $25M

Khatabook provides a mobile app that allows business owners to digitally record customer credit and debit transactions, replacing paper ledgers; the platform also offers access to lending services and is designed for small businesses managing customer accounts.

FintechBengaluru, IN

Ravish Naresh(CEO)inAshish Sonone(Founder)Gaurav Lahoti(Founder)Jaideep Poonia(Founder)Rishabh Gupta(Founder)Vaibhav Kalpe(Founder)

Co-investorsAlkeon InnovationAlpha Wave GlobalAngel Collective Opportunity FundB Capital GroupB4 CapitalBetter Capital+29 more

Pristyn Carepristyncare.comin𝕏Series B · Dec 2019 · $12M

Pristyn Care operates a network of clinics across India offering various medical specialities including proctology, laparoscopy, gynaecology, ENT, urology, and other surgical and medical services.

B2B MarketplacesDigital HealthHealthtechMedical DevicesDelhi, IN

Dr. Garima Sawhney(Founder)inDr Vaibhav Kapoor(Founder)inHarsimarbir (Harsh) Singh(Founder)inGarima Sawhney(Founder)Harsimarbir Singh(Founder)Vaibhav Kapoor(Founder)

Co-investorsEpiq Capital Investment Advisory LLPTenacity VenturesTrifecta Capital AdvisorsAstir VenturesGreenoaksSequoia Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.